Istodax and Bactrim drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Istodax (romidepsin) and Bactrim (sulfamethoxazole; trimethoprim). Common drug interactions include thrombocytopenia among females and cardiac failure among males.

The phase IV clinical study analyzes what interactions people have when they take Istodax and Bactrim. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Istodax?

Istodax has active ingredients of romidepsin. eHealthMe is studying from 1,054 Istodax users. Check the latest studies of Istodax.

What is Bactrim?

Bactrim has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 89,117 Bactrim users. Check the latest studies of Bactrim.



On Aug, 09, 2026

49 people who take Istodax and Bactrim together, and have interactions are studied.

Istodax and Bactrim drug interactions.

What are the common drug interactions of Istodax and Bactrim, by gender? *:

female:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Bone marrow failure
  3. Hepatic failure (liver failure)
  4. Anaemia (lack of blood)
  5. Pyoderma gangrenosum (ulcerating condition of skin that results in heaped borders with a typical appearance)
  6. Ulcer
  7. Haematotoxicity (toxins that destroy red blood cells)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  10. Platelet disorder

male:

  1. Cardiac failure
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Melaena (the passage of black, tarry stools)
  4. Neutropenia (an abnormally low number of neutrophils)
  5. Skin ulcer
  6. Cerebral haemorrhage (bleeding within the brain)
  7. Dyspnoea (difficult or laboured respiration)
  8. Hodgkin's disease (cancer originating from white blood cells)
  9. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Istodax and Bactrim, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hodgkin's disease (cancer originating from white blood cells)
  2. Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
  3. Blood bilirubin increased
  4. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)

40-49:

  1. Electrocardiogram qt prolonged
  2. Angioimmunoblastic t-cell lymphoma (mature t-cell cancer of the blood or lymph vessel)

50-59:

  1. Bone marrow failure
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Hepatic failure (liver failure)
  4. Cerebral haemorrhage (bleeding within the brain)
  5. Hypercalcaemia (elevated calcium (ca+) level in the blood)
  6. Hypotension (abnormally low blood pressure)
  7. Multiple myeloma (cancer of the plasma cells)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Platelet disorder
  10. Pyrexia (fever)

60+:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Cardiac failure
  3. Cardiac arrest
  4. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  5. Klebsiella sepsis (klebsiella causes a potentially fatal whole-body inflammation)
  6. Tumour invasion (starting of tumour)
  7. Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
  8. Melaena (the passage of black, tarry stools)
  9. Skin ulcer
  10. General physical health deterioration (weak health status)

What are the existing conditions these people have? *

  1. T-Cell Lymphoma (a blood cell cancer): 13 people, 26.53%
  2. Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 10 people, 20.41%
  3. Angioimmunoblastic T-Cell Lymphoma (mature t-cell cancer of the blood or lymph vessel): 8 people, 16.33%
  4. Lymphoma (cancer that begins in immune system cells): 7 people, 14.29%
  5. Stress And Anxiety: 5 people, 10.20%
  6. Pain: 5 people, 10.20%
  7. Depression: 5 people, 10.20%
  8. Neuropathy Peripheral (surface nerve damage): 4 people, 8.16%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 8.16%
  10. High Blood Pressure: 4 people, 8.16%

* Approximation only. Some reports may have incomplete information.

Do you take Istodax and Bactrim?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Istodax and Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Istodax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Istodax and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactrim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on romidepsin and sulfamethoxazole; trimethoprim (the active ingredients of Istodax and Bactrim, respectively), and Istodax and Bactrim (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: